AbCellera Biologics Inc. Common Shares (ABCL) 1WAbCellera Biologics, Inc.BATS:ABCLTotoshkaTradesABCL On the weekly timeframe, a strong long setup is forming, marking the end of a multi-year downtrend and the formation of a solid base for medium-term growth. The key technical argument is the classic mirror level in the 5.32–5.80 range, which previously held back buyers for a long time and is now successfully being tested from above as a new support zone. The bullish case is strengthened by price holding above all key moving averages, which are now turning upward, forming an additional protective shield for the uptrend. A clean impulsive breakout from the global descending trendline has been confirmed, so the current consolidation represents a healthy technical retest of the broken structure. Position building is relevant within the current buy zone, where the appearance of long lower wicks on weekly candles clearly confirms that large players are defending this range. The main medium-term profit target is located at strong historical resistance around 14.97 dollars, which, given current entry levels, offers an excellent risk-to-reward ratio. This analysis is for informational purposes only and does not constitute individual investment advice. Proper risk management is required.